Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study.

P Roach, R Francis, L Emmett, M McCarthy, A Scott - 2017 - Soc Nuclear Med
706 Objectives: Ga68-Prostate Specific Membrane Antigen (PSMA) PET/CT is being
increasingly used in the assessment of patients with prostate cancer. The aim of this study …

The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study

PJ Roach, R Francis, L Emmett, E Hsiao… - Journal of Nuclear …, 2018 - Soc Nuclear Med
68Ga-PSMA PET/CT scanning has been shown to be more sensitive than conventional
imaging techniques in patients with prostate cancer. This prospective Australian multicenter …

Utility of Ga68 prostate‐specific membrane antigen positron‐emission tomography for pre‐operative staging of high‐risk prostate cancer in a prospective cohort

GP Tarr, P Kashyap, DD Dixit… - Journal of Medical …, 2020 - Wiley Online Library
Introduction To assess the yield of Ga68 PSMA PET/CT added to the conventional staging of
high‐risk prostate cancer in terms of altered staging and changes to management. Methods …

The “ProPSMA Study” clinical trial protocol: A prospective randomized multi-center study of the impact of Ga-68 PSMA PET/CT imaging for staging high-risk prostate …

M Hofman, DG Murphy, S Williams, T Nzenza… - 2019 - ascopubs.org
TPS138 Background: Disease persistence or relapse following curative-intent surgery or
radiotherapy of high-risk prostate cancer is not uncommon. This is attributable, in part, to a …

Ga-68 PSMA 11 PET/MRI in Patients with Newly Diagnosed Intermediate and High-Risk Prostate Cancers

C Zacharias, C Harrison, P Ghanouni, G Sonn… - 2017 - Soc Nuclear Med
537 Objectives: Ga-68 PSMA 11 is now used worldwide to evaluate patients with prostate
cancer (PC). In this study, we investigated the accuracy of Ga-68 PSMA 11 PET/MRI …

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate …

MS Hofman, DG Murphy, SG Williams… - BJU …, 2018 - Wiley Online Library
Background Accurate staging of patients with prostate cancer (PC a) is important for
therapeutic decision‐making. Relapse after surgery or radiotherapy of curative intent is not …

[HTML][HTML] Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy

NS Schmidt-Hegemann, WP Fendler, A Buchner… - Radiation …, 2017 - Springer
Background To determine the potential role of 68 Ga-PSMA positron emission
tomography/computed tomography (PET/CT) in radiotherapy (RT) planning for prostate …

Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer.

E Algın, B Okudan, Y Açıkgöz, H Sayan… - Current Medical …, 2024 - europepmc.org
Background 68Ga-labeled prostate-specific membrane antigen positron emission
tomography-computed tomography (68Ga-PSMA PET/CT) has led to altered treatment plans …

68Ga-PSMA PET/CT impact on prostate cancer management

A Afaq, S Alahmed, S Chen, T Lengana… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Aim: To assess the impact of 68 Ga-Prostate Specific Membrane Antigen (PSMA) Positron
Emission Tomography/Computed Tomography (PET/CT) on management of prostate cancer …

The clinical consequences of routine 68Ga-PSMA-11 PET/CT in patients with newly diagnosed prostate cancer, ISUP grade 5 and no metastases based on standard …

HD Zacho, S Nalliah, A Petersen… - Scandinavian Journal of …, 2022 - Taylor & Francis
Aim To evaluate the clinical consequences of prostate specific membrane antigen (PSMA)
PET/CT for primary staging in patients with ISUP grade 5 (Gleason score≥ 9) prostate …